ESMO Preceptorship on Prostate Cancer 2015

Oncology Meeting Resources

09 Apr - 10 Apr, Prague, Czech Republic

ESMO Preceptorship on Prostate Cancer

The aims of this Preceptorship were to learn the fundamentals of epidemiology, natural history and diagnosis as contributing factors to heterogeneity in prostate cancer; understand essentials in the assessment and multidisciplinary treatment of prostate cancer, and learn about advances in treatment and novel targets in prostate cancer.

On this page, you may download the PDF of presentations given at the ESMO Preceptorship on Prostate Cancer 2015 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Useful links

Presenter Presentation title Session title
Alan Horwich Welcome from ESMO, objectives and scientific introduction Opening and Welcome
Ferran Algaba Familial genetics, carcinogenesis and morphogenesis Screening, diagnosis and staging
Ferran Algaba Diagnosis, and impact of pathology and genentic changes on prognosis Screening, diagnosis and staging
Michael Kolinsky An unusual case of metastatic prostate cancer Localised prostate cancer
Pasquale Rescigno Is mCRPC a curable disease? Localised prostate cancer
Mathew Tony Small cell carcinoma of prostate case Localised prostate cancer
Valerie Fontayne Role of radiotherapy Localised prostate cancer
Alan Horwich Active surveillance in early prostate cancer Localised prostate cancer
Theo M. de Reijke Role of surgery Localised prostate cancer
Gedske Daugaard Value and role of PSA as a tumour marker of response/relapse Advanced prostate cancer
Theo M. de Reijke Debate: locally-advanced prostate cancer should not be treated with radiotherapy and hormone deprivation Advanced prostate cancer
Giuseppe Viscardi Case presentation Advanced prostate cancer
Valerie Fontayne Debate: locally-advanced prostate cancer should be treated with radiotherapy and hormone deprivation Advanced prostate cancer
Theo M. de Reijke Urinary obstruction Advanced prostate cancer
Theo M. de Reijke Presentation with lymphadenopathy Advanced prostate cancer